Viewing Study NCT05821192


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-05-20 @ 10:26 AM
Study NCT ID: NCT05821192
Status: UNKNOWN
Last Update Posted: 2023-04-20
First Post: 2023-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
Sponsor: Ou Bai, MD/PHD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T-Cell Lymphoma, Not Otherwise Specified View
None Angioimmunoblastic T-cell Lymphoma View
Keywords: